Diagnosis, management, and prevention of rotavirus gastroenteritis in children

BMJ (Online)

Volumn 347, Issue , 2013, Pages

  Parashar, Umesh D ^a   Nelson, E Anthony S ^b   Kang, Gagandeep ^c  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MATERNAL ANTIBODY; NITAZOXANIDE; ONDANSETRON; PROBIOTIC AGENT; ROTAVIRUS VACCINE; ZINC;

ANTIBODY RESPONSE; BREAST FEEDING; CHILD HEALTH CARE; CLINICAL FEATURE; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INFECTION RISK; INFECTIOUS DIARRHEA; NONHUMAN; ORAL REHYDRATION THERAPY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; ROTAVIRUS INFECTION; VACCINATION; VIRAL GASTROENTERITIS; VIRUS DETECTION; VIRUS PATHOGENESIS;

EID: 84891798461     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f7204     Document Type: Review

References (69)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9: 565-72. (Pubitemid 36529515)
2. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012;12: 136-41.
3. Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE, et al. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review. PLoS One 2013;8:e72788.
4. Dickey M, Jamison L, Michaud L, Care M, Bernstein DI, Staat MA. Rotavirus meningoencephalitis in a previously healthy child and a review of the literature. Pediatr Infect Dis J 2009;28: 318-21.
5. Le Saux N, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW. Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J 2010;29: 879-82.
6. Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335: 1022-8. (Pubitemid 26338732)
7. Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 2011;365: 337-46.
8. Anderson EJ, Weber SG. Rotavirus infection in adults. Lancet Infect Dis 2004;4: 91-9. (Pubitemid 38169275)
9. Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 1999;103:E3.
10. Dennehy PH, Cortese MM, Bégué RE, Jaeger JL, Roberts NE, Zhang R, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in US children. Pediatr Infect Dis J 2006;25: 1123-31. (Pubitemid 44900675)
11. Patel MM, Pitzer VE, Alonso WJ, Vera D, Lopman B, Tate J, et al. Global seasonality of rotavirus disease. Pediatr Infect Dis J 2013;32:e134-47.
12. Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis 1986;154: 871-80. (Pubitemid 17181614)
13. Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 2009;136: 1939-51.
14. Richardson S, Grimwood K, Gorrell R, Palombo E, Barnes G, Bishop R. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998;351: 1844-8. (Pubitemid 28279708)
15. Boshuizen JA, Reimerink JH, Korteland-van Male AM, van Ham VJ, Koopmans MP, Büller HA, et al. Changes in small intestinal homeostasis, morphology, and gene expression during rotavirus infection of infant mice. J Virol 2003;77: 13005-16. (Pubitemid 37494296)
16. Blutt SE, Kirkwood CD, Parreño V, Warfield KL, Ciarlet M, Estes MK, et al. Rotavirus antigenaemia and viraemia: a common event? Lancet 2003;362: 1445-9. (Pubitemid 37352880)
17. Kang G, Iturriza-Gomara M, Wheeler JG, Crystal P, Monica B, Ramani S, et al. Quantitation of group A rotavirus by real-time reverse-transcription- polymerase chain reaction: correlation with clinical severity in children in South India. J Med Virol 2004;73: 118-22. (Pubitemid 38429157)
18. Herring AJ, Inglis NF, Ojeh CK, Snodgrass DR, Menzies JD. Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol 1982;16: 473-7. (Pubitemid 12050038)
19. Thomas EE, Puterman ML, Kawano E, Curran M. Evaluation of seven immunoassays for detection of rotavirus in pediatric stool samples. J Clin Microbiol 1988;26: 1189-93.
20. Iturriza Gómara M, Kang G, Gray JJ. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 2004;31: 259-65. (Pubitemid 39371057)
21. Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database Syst Rev 2013;1:CD005436.
22. Gregorio GV, Dans LF, Silvestre MA. Early versus delayed refeeding for children with acute diarrhoea. Cochrane Database Syst Rev 2011;7:CD007296.
23. Fedorowicz Z, Jagannath VA, Carter B. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev 2011;9:CD005506.
24. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010;11:CD003048.
25. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev 2009;2:CD006519.
26. Guideline Development Group. Diarrhoea and vomiting caused by gastroenteritis: diagnosis, assessment and management in children younger than 5 years. National Collaborating Centre for Women's and Childrens Health, 2009. www.nice.org.uk/nicemedia/ pdf/CG84FullGuideline.pdf.
27. Hartling L, Bellemare S, Wiebe N, Russell K, Klassen TP, Craig W. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev 2006;3:CD004390.
28. Hahn S, Kim S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database Syst Rev 2002;1:CD002847.
29. Nelson EA, Ko WK, Kwan E, Leung SF, Poon KH, Chow CB, et al. Guidelines for the management of acute diarrhoea in young children. Hong Kong J Paediatr 2003;8: 203-36.
30. Armon K, Stephenson T, MacFaul R, Eccleston P, Werneke U. An evidence and consensus based guideline for acute diarrhoea management. Arch Dis Child 2001;85: 132-42.
31. Murphy MS. Guidelines for managing acute gastroenteritis based on a systematic review of published research. Arch Dis Child 1998;79: 279-84. (Pubitemid 28420524)
32. Goldman RD, Friedman JN, Parkin PC. Validation of the clinical dehydration scale for children with acute gastroenteritis. Pediatrics 2008;122: 545-9.
33. Gorelick MH, Shaw KN, Murphy KO. Validity and reliability of clinical signs in the diagnosis of dehydration in children. Pediatrics 1997;99:E6.
34. Alberta Health Service. Alberta Health Services acute childhood vomiting and diarrhea pathway. 2011. http://pert.ucalgary.ca/pathways/reference/ Revised%20ED-UCC% 20pathway%20Oct%2025%202011.pdf.
35. Lewis KDC, Dallas MJ, Victor JC, Ciarlet M, Mast TC, Ji M, et al. Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia. Vaccine 2012;30(suppl 1):A159-66.
36. Freedman SB, Eltorky M, Gorelick M; Pediatric Emergency Research Canada Gastroenteritis Study Group. Evaluation of a gastroenteritis severity score for use in outpatient settings. Pediatrics 2010;125:e1278-85.
37. Van den Berg J, Berger MY. Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and applicability in primary care. BMC Fam Pract 2011;12:134.
38. Lo Vecchio A, Giannattasio A, Duggan C, De Masi S, Ortisi MT, Parola L, et al. Evaluation of the quality of guidelines for acute gastroenteritis in children with the AGREE instrument. J Pediatr Gastroenterol Nutr 2011;52: 183-9.
39. Pringle K, Shah SP, Umulisa I, Munyaneza RBM, Dushimiyimana JM, Stegmann K, et al. Comparing the accuracy of the three popular clinical dehydration scales in children with diarrhea. Int J Emerg Med 2011;4:58.
40. WHO. The treatment of diarrhoea: a manual for physicians and other senior health workers. 4th ed. 2005. http://whqlibdoc.who.int/publications/2005/ 9241593180.pdf.
41. Lawson AL. Acute gastroenteritis and dehydration (child). Li STT, Ebell MH, eds. Essential Evidence 2012. www.essentialevidenceplus.com/content/eee? class=GI.
42. Dalby-Payne J, Elliott E. Gastroenteritis in children. Clin Evid 2011;07:314.
43. Rossignol JF, Abu-Zekry M, Hussein A, Santoro MG. Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial. Lancet 2006;368: 124-9. (Pubitemid 43994153)
44. Sarker SA, Jäkel M, Sultana S, Alam NH, Bardhan PK, Chisti MJ, et al. Anti-rotavirus protein reduces stool output in infants with diarrhea: a randomized placebo-controlled trial. Gastroenterology 2013;145:740-8.e8.
45. Sarker SA, Casswall TH, Juneja LR, Hoq E, Hossain I, Fuchs GJ, et al. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr 2001;32: 19-25. (Pubitemid 32094491)
46. Clemens J, Rao M, Ahmed F, Ward R, Huda S, Chakraborty J, et al. Breast-feeding and the risk of life-threatening rotavirus diarrhea: prevention or postponement? Pediatrics 1993;92: 680-5. (Pubitemid 23318988)
47. Centers for Disease Control and Prevention. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Morb Mortal Wkly Rep 1999;48(RR-2).
48. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine - United States, 1998-1999. Morb Mortal Wkly Rep 1999;48: 577-81.
49. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001;344: 564-72. (Pubitemid 32167870)
50. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354: 11-22. (Pubitemid 43048947)
51. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354: 23-33. (Pubitemid 43048948)
52. WHO. Meeting of the strategic advisory group of experts on immunization, October 2009 - conclusions and recommendations. Wkly Epidemiol Rec 2009;84:518.
53. Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect Dis 2012;12: 561-70.
54. Gastañaduy PA, Curns AT, Parashar UD, Lopman BA. Gastroenteritis hospitalizations in older children and adults in the United States before and after implementation of infant rotavirus vaccination. JAMA 2013;310: 851-3.
55. Zlamy M, Kofler S, Orth D, Würzner R, Heinz-Erian P, Streng A, et al. The impact of rotavirus mass vaccination on hospitalization rates, nosocomial rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis 2013;13:112.
56. De Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 2011;8:e1001024.
57. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010;362: 299-305.
58. Carlin JB, Macartney K, Lee KJ, Quinn HE, Buttery J, Lopert R, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's national immunisation program. Clin Infect Dis 2013; published online 30 Aug.
59. Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011;29: 3061-6.
60. Patel M, López-Collada V, Bulhões M, De Oliveira LH, Bautista Márquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011;364: 2283-92.
61. Velazquez FR, Colindres RE, Grajales C, Hernández MT, Mercadillo MG, Torres FJ, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012;31: 736-44.
62. Haber P, Patel M, Pan Y, Baggs J, Haber M, Museru O, et al. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. Pediatrics 2013;131: 1042-9.
63. Shui I, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US Infants. JAMA 2012;307: 598-604.
64. Cortese M. Estimates of benefits and potential risks of rotavirus vaccination in the US presented at the Advisory Committee on Immunization Practices meeting, Atlanta, GA, USA, 20 June 2013. www.cdc.gov/vaccines/acip/ meetings/downloads/slides-jun-2013/ 06-Rotavirus-Cortese.pdf.
65. Food and Drug Administration. Final study results of a mini-sentinel postlicensure observational study of rotavirus vaccines and intussusception. 2013. www.fda.gov/ BiologicsBloodVaccines/SafetyAvailability/ucm356758.htm.
66. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368: 323-32. (Pubitemid 44067224)
67. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376: 606-14.
68. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376: 615-23.
69. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010;362: 289-98.